Journal of the National Cancer Institute Advance Access originally published online on November 13, 2007
JNCI Journal of the National Cancer Institute 2007 99(22):1666-1667; doi:10.1093/jnci/djm241
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
NEWS |
Researchers Hope State Stem Cell Efforts Last
| The first 150 words of the full text of this article appear below. |
Several states are moving forward with efforts to fund studies involving human embryonic stem cells. Even though most of these programs are still in the embryonic stages themselves, they may prove to have an enduring effect on the field.
In August 2001, President Bush signed an executive order limiting the use of federal funds for research involving human embryonic stem cells to lines that were already established at the time. Even if the current federal policy were overturned, a law passed in 1995 already barred federally funded scientists from any work that destroys a human embryo, which is required to create a new cell line with current technology.
At least partly because of these federal policies, New Jersey became the first state to approve its own funding for embryonic stem cell research in 2004 and has appropriated $23 million for grants so far. Since then, California, Connecticut, Illinois, Maryland, Massachusetts,
A State By State Look at Stem Cell Funding
Private Donations Fill Gap
The Haves and Have Nots